share_log

諾輝健康：截至二零二四年二月二十九日止月份之股份發行人的證券變動月報表

NH HEALTH: Monthly Return of Equity Issuer on Movements in Securities for the month ended 29 February 2024

香港交易所 ·  Mar 6 01:08
Summary by Moomoo AI
諾輝健康（NH HEALTH）於2024年3月6日向香港交易及結算所有限公司提交了最新的證券變動月報表，報告截至2024年2月29日的公司股份變動情況。報告顯示，諾輝健康的法定/註冊股本及已發行股份在報告期內均無變動，普通股股份數目維持在1,000,000,000股，每股面值0.00005美元，總股本為50,000美元。已發行股份結存數目為457,813,108股。此外，根據2022年購股權計劃，公司於2022年6月24日採納的股份期權計劃中，本月內無新增股份期權變動，結存數目維持在18,239,768股。公司亦無因行使期權而得到的資金。報告還提到，公司於2023年6月9日購回的股份數目為9,058,500股，其中2,886,500股、5,285,500股及886,500股分別於2023年8月、9月及10月回購，但截至報告期末未註銷。諾輝健康確認，所有證券發行均已獲得董事會授權，並符合香港聯合交易所有限公司證券上市規則的相關要求。
諾輝健康（NH HEALTH）於2024年3月6日向香港交易及結算所有限公司提交了最新的證券變動月報表，報告截至2024年2月29日的公司股份變動情況。報告顯示，諾輝健康的法定/註冊股本及已發行股份在報告期內均無變動，普通股股份數目維持在1,000,000,000股，每股面值0.00005美元，總股本為50,000美元。已發行股份結存數目為457,813,108股。此外，根據2022年購股權計劃，公司於2022年6月24日採納的股份期權計劃中，本月內無新增股份期權變動，結存數目維持在18,239,768股。公司亦無因行使期權而得到的資金。報告還提到，公司於2023年6月9日購回的股份數目為9,058,500股，其中2,886,500股、5,285,500股及886,500股分別於2023年8月、9月及10月回購，但截至報告期末未註銷。諾輝健康確認，所有證券發行均已獲得董事會授權，並符合香港聯合交易所有限公司證券上市規則的相關要求。
NH HEALTH FILED ITS LATEST MONTHLY SECURITIES CHANGE REPORT WITH HONG KONG TRADING AND SETTLEMENT LIMITED ON MARCH 6, 2024, REPORTING CHANGES IN COMPANY SHARES FOR THE YEAR ENDED FEBRUARY 29, 2024. The report shows that Novi Healthcare's regulary/registered share capital and issued shares remained unchanged during the reporting period. The number of ordinary shares remained at 1,000,000,000 shares with a face value of $0.00005 per share and a total share capital of $50,000. The number of issued shares outstanding is 457,813,108 shares. In addition, under the 2022 Share Option Plan, the Company's stock option plan adopted on June 24, 2022 had no additional share option changes during the month, and the number of deposits remained at 18,239,768 shares. The Company also does not receive funds due to the...Show More
NH HEALTH FILED ITS LATEST MONTHLY SECURITIES CHANGE REPORT WITH HONG KONG TRADING AND SETTLEMENT LIMITED ON MARCH 6, 2024, REPORTING CHANGES IN COMPANY SHARES FOR THE YEAR ENDED FEBRUARY 29, 2024. The report shows that Novi Healthcare's regulary/registered share capital and issued shares remained unchanged during the reporting period. The number of ordinary shares remained at 1,000,000,000 shares with a face value of $0.00005 per share and a total share capital of $50,000. The number of issued shares outstanding is 457,813,108 shares. In addition, under the 2022 Share Option Plan, the Company's stock option plan adopted on June 24, 2022 had no additional share option changes during the month, and the number of deposits remained at 18,239,768 shares. The Company also does not receive funds due to the exercise of options. The report also notes that the Company repurchased as of June 9, 2023 was 9,058,500 shares, of which 2,886,500 shares, 5,285,500 shares and 886,500 shares were repurchased in August, September and October 2023, but were not written off as of the end of the reporting period. Novi Health confirms that all securities issues have been authorised by the Board of Directors and comply with the relevant requirements of the Listing Rules of the Stock Exchange of Hong Kong Stock Exchange Limited.

This announcement is a separate document:

Doc 1     View Translation

Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more